EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Equine bone marrow MSC ‐derived extracellular vesicles mitigate the inflammatory effects of interleukin‐1β on navicular tissues in vitro

Vivian G Quam, Zarah A Belacic, Sidney Long, Hilary C Rice, Madhu S Dhar, Sushmitha Durgam iD

Equine Veterinary Journal · 2025-01 · 57 (1) · 232-242

DOI: 10.1111/evj.14090 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Equine Veterinary Journal, online erschienen am 08.04.2024. Verfasst von Vivian G Quam und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Extracellular Vesicles, Mesenchymal Stem Cells, Interleukin-1beta. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, American College of Veterinary Surgeons Foundation 2019 Surgeon-in-Training Grant, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Safe, efficacious therapy for treating degenerate deep digital flexor tendon (DDFT) and navicular bone fibrocartilage (NBF) in navicular horses is critically necessary. While archetypal orthobiologic therapies for navicular disease are used empirically, their safety and efficacy are unknown. Mesenchymal stem cell‐derived extracellular vesicles (EV) may overcome several limitations of current orthobiologic therapies.

Objectives

To (1) characterise cytokine and growth factor profiles of equine bone marrow mesenchymal stem cell (BM‐MSC)‐derived extracellular vesicles (BM‐EV) and (2) evaluate the in vitro anti‐inflammatory and extracellular matrix (ECM) protective potentials of BM‐EV on DDFT and NBF explant co‐cultures in an IL‐1β inflammatory environment. Study design In vitro experimental study.

Methods

Cytokines (IL‐1β, IL‐6, IL‐10, IL‐1ra and TNF‐α) and growth factors (TGFβ1, VEGF, IGF1 and PDGF) in equine BM‐EV isolated via ultracentrifugation and precipitation methods were profiled. Forelimb DDFT and NBF explant co‐cultures from seven horses were exposed to media alone, or media containing 2 × 10 9 ± 0.1 × 10 9 particles/mL or 10 μg/mL BM‐EV (BM‐EV), 10 ng/mL interleukin‐1β (IL‐1β), or IL‐1β + BM‐EV for 48 h. Co‐culture media IL‐6, TNF‐α, MMP‐3, MMP‐13 concentrations and explant sulphated glycosaminoglycan (sGAG) content were quantified.

Results

IL‐6, IGF1 and VEGF concentrations were 102.1 (37.61–256.2) and 182.3 (163.1–226.3), 72.3 (8–175.6) and 2.4 (0.1–2.6), 108.3 (38.3–709.1) and 211.4 (189.1–318.2) pg/mL per 2 × 10 9 ± 0.1 × 10 9 particles/mL or 10 μg/mL 10 μg of BM‐EV isolated via ultracentrifugation and precipitation methods, respectively. Co‐culture media MMP‐3 in BM‐EV‐ ( p = 0.03) and BM‐EV + IL‐1β‐treated ( p = 0.01) groups were significantly lower than the respective media and IL‐1β groups. DDFT explant sGAG content of BM‐EV ( p = 0.003) and BM‐EV + IL‐1β groups were significantly higher compared with IL‐1β group. Main limitations Specimen numbers are limited, in vitro model may not replicate clinical case conditions, lack of non‐MSC‐derived EV control group.

Conclusions

Equine BM‐EV contains IL‐6 and growth factors, IGF1 and VEGF. The anti‐inflammatory and ECM protective potentials of BM‐EV were evident as increased IL‐6 and decreased MMP‐3 concentrations in the DDFT‐NBF explant co‐culture media. These results support further evaluation of BM‐EV as an acellular and ‘off‐the‐shelf’ intra‐bursal/intrasynovial therapy for navicular pathologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesMesenchymal Stem CellsInterleukin-1betaAnimalsHorsesInflammationCytokinesHorse DiseasesGene Expression RegulationCoculture TechniquesBone Marrow Cells

Stichwörter der Autor:innen

bone marrow MSCdeep digital flexor tendonextracellular vesicleshorsenavicular fibrocartilage

Substanzen

Interleukin-1betaCytokines

Autor:innen und Institutionen

  • Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, USA.
  • Ballarat Veterinary Practice Equine Clinic, Miners Rest, Victoria, Australia.
  • Department of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee, USA.

ORCID-Profile: Sushmitha Durgam

Förderung

  • NCATS NIH HHS
  • American College of Veterinary Surgeons Foundation 2019 Surgeon-in-Training Grant
  • National Center for Advancing Translational Sciences

Zitieren

APA

Quam, V. G., Belacic, Z. A., Long, S., Rice, H. C., Dhar, M. S., & Durgam, S. (2025). Equine bone marrow MSC ‐derived extracellular vesicles mitigate the inflammatory effects of interleukin‐1β on navicular tissues in vitro. Equine Veterinary Journal, 57(1), 232-242. https://doi.org/10.1111/evj.14090

Vancouver

Quam VG, Belacic ZA, Long S, Rice HC, Dhar MS, Durgam S. Equine bone marrow MSC ‐derived extracellular vesicles mitigate the inflammatory effects of interleukin‐1β on navicular tissues in vitro. Equine Veterinary Journal. 2025;57(1):232-242. doi:10.1111/evj.14090

BibTeX
@article{Quam2025,
  author = {Quam, Vivian G and Belacic, Zarah A and Long, Sidney and Rice, Hilary C and Dhar, Madhu S and Durgam, Sushmitha},
  title = {Equine bone marrow MSC ‐derived extracellular vesicles mitigate the inflammatory effects of interleukin‐1β on navicular tissues in vitro},
  journal = {Equine Veterinary Journal},
  year = {2025},
  volume = {57},
  number = {1},
  pages = {232--242},
  doi = {10.1111/evj.14090}
}
Kostenlos starten →